Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP block for pain control in gastric bypass
NCT03203070Phase 3Unknown
- Sponsor
- Hospital General Universitario de Elche
- Start
- Mar 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Hospital General Universitario de Elche. Primary endpoint: Visual Analogic Scale at 24 hours. Status: unknown.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03203070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03203070.